MARKER THERAPEUTICS, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
MARKER THERAPEUTICS, INC. (MRKR) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $735.93 thousand for the 6-month period ending 2016-06-30, per its 10-Q filed 2016-08-15.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2016-08-15
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2016-06-30 was $330.68K.
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2016-03-31 was $405.25K.
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2011 was $456.08K, a 59.80% decline from fiscal 2010.
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2010 was $1.13M, a 45.77% decline from fiscal 2009.
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2009 was $2.09M, a 793.33% increase from fiscal 2008.
- MARKER THERAPEUTICS, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2008 was $234.17K, a 74.12% decline from fiscal 2007.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2016-06-30 | $330.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $735.93K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $405.25K 10-Q · filed 2016-05-16 | ||
| 2011-12-31 | $456.08K 10-K · filed 2012-04-16 | ||
| 2010-12-31 | $1.13M 10-K · filed 2012-04-16 | ||
| 2009-12-31 | $2.09M 10-K · filed 2012-04-16 | ||
| 2008-12-31 | $234.17K 10-K · filed 2012-04-16 | ||
| 2007-12-31 | $904.82K 10-K · filed 2012-04-16 | ||
| 2004-12-31 | $73.50K 10-K · filed 2012-04-16 | ||
| 2003-12-31 | $2.73M 10-K · filed 2012-04-16 | ||
| 2002-12-31 | $630.27K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |